Rankings
▼
Calendar
NXTC FY 2022 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$36M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$76M
Net Income
-$75M
EPS (Diluted)
$-32.32
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$56M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$184M
Total Liabilities
$17M
Stockholders' Equity
$168M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$76M
-$71M
-7.3%
Net Income
-$75M
-$69M
-7.7%
← Q4 2021
All Quarters
Q1 2022 →